Rhonda Facile has over 30 years of clinical research and standards development experience. She has worked in a global Contract Research Organization (CRO), global Standards Development Organizations (SDO) and in pharmaceutical and biotechnology companies in the United States and abroad. She has experience in clinical trial monitoring, program management, regulatory affairs and standards development.
At CDISC, Rhonda Facile was VP, Partnerships and Develop at CDISC led numerous standards development projects, including CDASH and therapeutic area standards under the Coalition For Accelerating Standards and Therapies (CFAST) initiative. Rhonda brings together key and diverse stakeholder communities, including the clinical community, global regulatory authorities, national health agencies, global biopharmaceutical companies and vendor organizations to forward clinical informatics and the use of CDISC standards. Rhonda represented CDISC at ISO TC215, the HL7 Accelerator Vulcan Operations Committee and at numerous other collaborative organizations and partnerships.
Now at HL7 Europe, Rhonda brings these years of experience to support operations, project management and communications. These are all at the service of a global effort to improve healthcare interoperability using the internationally recognized HL7 standards that support the exchange, integration, sharing and retrieval of electronic health information that supports clinical practice and the management, delivery and evaluation of health services. Rhonda holds an MS from St. Edwards University and a BA from the University of Texas at Austin.
Rhonda has instantiated the body of peer-reviewed articles on CDISC standards implementation published in the Journal of the Society of Clinical Data Management (SCDM) and has authored and co-authored publications that are published in journals such as Journal of Medical Internet Research (JMIR) and Drug Discovery, and in several meeting proceedings. Rhonda also contributed to chapters in a textbook edited by the Multi-Regional Clinical Trials Center (MRCT) of Brigham and Women’s Hospital and Harvard. Rhonda has presented at numerous conferences and meetings the world over.